Video Library Update

Our Video & Webinar Library has recently been updated with many new additions.

First, Scott Berry presents, "The Design of Complex Adaptive Trials" at the recent conference co-sponsored by Berry Consultants, "Transforming Drug Development – Delivering Innovation and Efficiency through Adaptive Clinical Trials" in Bethesda, MD.

In the second, is an Educational Webinar Series of three new webinars.  Scott Berry and Roger Lewis join William Meurer of University of Michigan to create these webinars on "Adaptive Clinical Trials" for the Clinical & Translational Science Awards Consortium (CTSA).

Lastly, Don Berry describes in a webinar, "Challenges in Developing Drugs in the Modern Era of Cancer" the challenges brought by improved understanding of cancer biology and how new trial designs can efficiently address these developments bring.

To view these, as well as others, visit our Video & Webinar Library here

 

More Recent News

February 2024 QUOTES Webinar

Berry Consultants will be hosting a webinar on the optimization of a clinical trial design by estimating its impact on the expected net present value of a drug development program using the software QUOTES (Quantification and Optimization of Trial Expectations Simulator).

Blog: Precision Promise Adaptive Platform Trial update

Blog by: Kert Viele News from the Precision Promise platform trial. https://fibrogen.gcs-web.com/news-releases/news-release-details/fibrogen-announces-completion-pamrevlumab-arm-precision-promise Precision Promise is an adaptive platform trial investigating potential therapies for pancreatic cancer,

January 2024 FACTS Webinar

The Berry Consultants software team will be hosting its January FACTS webinar next Friday, January 19th at 11am EST to present the development plans for adding an ordinal endpoint option to the trial simulator.

Blog: Comments on the draft FDA master protocol guidance

Blog by: Kert Viele The FDA draft master protocol guidance is out https://www.fda.gov/regulatory-information/search-fda-guidance-documents/master-protocols-drug-and-biological-product-development Comments are due by February 22. Here are some preliminary thoughts and